Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
4.550
+0.070 (1.56%)
Apr 1, 2026, 9:35 AM EDT - Market open
Abeona Therapeutics Revenue
In the year 2025, Abeona Therapeutics had annual revenue of $5.82M. Abeona Therapeutics had revenue of $3.00M in the quarter ending December 31, 2025.
Revenue (ttm)
$5.82M
Revenue Growth
n/a
P/S Ratio
43.91
Revenue / Employee
$25,752
Employees
226
Market Cap
259.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.82M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 3.50M | 2.09M | 147.52% |
| Dec 31, 2022 | 1.41M | -1.59M | -52.87% |
| Dec 31, 2021 | 3.00M | -7.00M | -70.00% |
| Dec 31, 2020 | 10.00M | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 3.00M | 2.16M | 258.18% |
| Dec 31, 2017 | 837.00K | -52.00K | -5.85% |
| Dec 31, 2016 | 889.00K | -151.00K | -14.52% |
| Dec 31, 2015 | 1.04M | 115.00K | 12.43% |
| Dec 31, 2014 | 925.00K | -1.12M | -54.70% |
| Dec 31, 2013 | 2.04M | -2.36M | -53.63% |
| Dec 31, 2012 | 4.40M | 2.57M | 139.48% |
| Dec 31, 2011 | 1.84M | 1.36M | 282.33% |
| Dec 31, 2010 | 481.00K | 129.00K | 36.65% |
| Dec 31, 2009 | 352.00K | 61.00K | 20.96% |
| Dec 31, 2008 | 291.00K | 234.00K | 410.53% |
| Dec 31, 2007 | 57.00K | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Coherus Oncology | 42.17M |
| Editas Medicine | 40.52M |
| C4 Therapeutics | 35.95M |
| Orchestra BioMed Holdings | 33.48M |
| Sol-Gel Technologies | 19.39M |
| Silence Therapeutics | 559.00K |
| SAB Biotherapeutics | 114.70K |
| Adlai Nortye | -1.35M |
ABEO News
- 12 days ago - Abeona Therapeutics: Maintaining 'Buy' On ZEVASKYN Launch Potential For RDEB - Seeking Alpha
- 14 days ago - Abeona Therapeutics Inc. (ABEO) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 23 days ago - Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch - GlobeNewsWire
- 4 weeks ago - Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas - GlobeNewsWire